探索肉毒毒素对马塞特缩的影响:一个随机的,三重失明的临床试验
Bryanne Brissian de Souza Nobre1, Luciana Rezende1, Mariana Barbosa Câmara-Souza1
1Department of Dentistry, Ingá University Center, Uningá, Paraná, Brazil.
Scientific reports
|June 24, 2024
概括
毒素A (BoNT-A) 有效地降低了MH并改善了面部外观. 然而,多次BoNT-A注射可能会导致按摩器肌肉的功能性不良影响.
科学领域:
- 整形外科 整形外科 整形外科
- 神经学 神经学
- 生物医学工程 生物医学工程
背景情况:
- 马塞特高 (MH) 导致面部不对称和美学问题.
- 毒素A (BoNT-A) 注射是 MH 的常见治疗方法.
- 了解BoNT-A的长期影响和潜在不良事件至关重要.
研究的目的:
- 评估单次和多次BoNT-A注射对MH的疗效和功能性不良影响.
- 评估肌肉厚度,电活动,性能和主观感知的变化.
主要方法:
- 26名患有MH的女性接受了75个单位的阿博托毒素每一个masseter.
- 3个月后,患者接受了盐水 (G1) 或重复BoNT-A (G2) 注射.
- 评估包括超声波,电肌图 (EMG),功能测试和1,3个月和6个月的主观评估.
主要成果:
- 在6个月后,G2组观察到左肌肉厚度的显著下降.
- 在6个月后,G1观察到更高的质量器EMG活性.
- 没有发现功能的显著差异,但G2显示1个月后MH的主观感知有所改善.
结论:
- 博恩特-A是有效的治疗masseter缩,导致减少肌肉厚度和改善的主观结果.
- 多次BoNT-A注射可能会对按摩器肌肉活动产生功能性不良影响.
- 需要进一步的研究来优化BoNT-A对MH的治疗方案.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
672
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
672
Skeletal Muscle Relaxants: Therapeutic Uses
480
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
480
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K


